Imperial College London

ProfessorSebastianJohnston

Faculty of MedicineNational Heart & Lung Institute

Asthma UK Clinical Chair
 
 
 
//

Contact

 

+44 (0)7931 376 544s.johnston

 
 
//

Assistant

 

Mr Christophe Tytgat +44 (0)20 7594 3849

 
//

Location

 

343Norfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Edwards:2017:10.1183/13993003.02448-2016,
author = {Edwards, MR and Saglani, S and Schwarze, J and Skevaki, C and Smith, JA and Ainsworth, B and Almond, M and Andreakos, E and Belvisi, MG and Chung, KF and Cookson, W and Cullinan, P and Hawrylowicz, C and Lommatzsch, M and Jackson, D and Lutter, R and Marsland, B and Moffatt, M and Thomas, M and Virchow, JC and Xanthou, G and Edwards, J and Walker, S and Johnston, SL and members, of the EARIP WP2 working group},
doi = {10.1183/13993003.02448-2016},
journal = {European Respiratory Journal},
title = {Addressing unmet needs in understanding asthma mechanisms: From the European Asthma Research and Innovation Partnership (EARIP) Work Package (WP)2 collaborators},
url = {http://dx.doi.org/10.1183/13993003.02448-2016},
volume = {49},
year = {2017}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Asthma is a heterogeneous, complex disease with clinical phenotypes that incorporate persistent symptoms and acute exacerbations. It affects many millions of Europeans throughout their education and working lives and puts a heavy cost on European productivity. There is a wide spectrum of disease severity and control. Therapeutic advances have been slow despite greater understanding of basic mechanisms and the lack of satisfactory preventative and disease modifying management for asthma constitutes a significant unmet clinical need. Preventing, treating and ultimately curing asthma requires co-ordinated research and innovation across Europe. The European Asthma Research and Innovation Partnership (EARIP) is an FP7-funded programme which has taken a co-ordinated and integrated approach to analysing the future of asthma research and development. This report aims to identify the mechanistic areas in which investment is required to bring about significant improvements in asthma outcomes.
AU - Edwards,MR
AU - Saglani,S
AU - Schwarze,J
AU - Skevaki,C
AU - Smith,JA
AU - Ainsworth,B
AU - Almond,M
AU - Andreakos,E
AU - Belvisi,MG
AU - Chung,KF
AU - Cookson,W
AU - Cullinan,P
AU - Hawrylowicz,C
AU - Lommatzsch,M
AU - Jackson,D
AU - Lutter,R
AU - Marsland,B
AU - Moffatt,M
AU - Thomas,M
AU - Virchow,JC
AU - Xanthou,G
AU - Edwards,J
AU - Walker,S
AU - Johnston,SL
AU - members,of the EARIP WP2 working group
DO - 10.1183/13993003.02448-2016
PY - 2017///
SN - 1399-3003
TI - Addressing unmet needs in understanding asthma mechanisms: From the European Asthma Research and Innovation Partnership (EARIP) Work Package (WP)2 collaborators
T2 - European Respiratory Journal
UR - http://dx.doi.org/10.1183/13993003.02448-2016
UR - http://www.ncbi.nlm.nih.gov/pubmed/28461300
UR - http://hdl.handle.net/10044/1/45616
VL - 49
ER -